Compare
The same information, side by side.
Put two companies next to each other and see where their numbers differ.
First company
Moderna (MRNA)
Second company
| Metric | ModernaMRNA | Choose a second company |
|---|---|---|
| Fiscal year shown | FY2025, ended December 2025 | |
| Sector · Industry | Health care · Biotechnology | |
| $258.38Close on Nov 4, 2026 | ||
| +988% | ||
| −9.0% | ||
| $103.2B | ||
| $1.94B | ||
| −39.9% | ||
| −$2.82B | ||
| −145% | ||
| −$2.06B | ||
| $5.14B | ||
| $591.0M | ||
| 0% | ||
| Advanced metricsAdvanced | ||
| −24.1% | ||
| 55.3% | ||
| −158% | ||
| −106% | ||
| 46.3 | ||
| 0.07 | ||
| 1.13 | ||
The same numbers, side by side. StockLab doesn't rank companies or pick between them. Fiscal years can end in different months, so check the first row.